Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pilot study of duloxetine in depressed patients with Parkinson's disease
2006-006043-32Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of duloxetine in major depressive disorder (MDD) and Parkinson's disease (PD), sponsored by Eli Lilly and Company. Primary endpoint: Primary tolerability endpoint. Started Mar 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-006043-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006043-32.